Premium
Drug Safety in Pregnant Women and Their Babies: Ignorance Not Bliss
Author(s) -
Chambers C D,
Polifka J E,
Friedman J M
Publication year - 2008
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100448
Subject(s) - bliss , clinical pharmacology , ignorance , medicine , pregnancy , population , alternative medicine , drug , clinical trial , family medicine , intensive care medicine , psychiatry , pharmacology , environmental health , computer science , pathology , political science , law , biology , genetics , programming language
Although clinical trials address questions regarding drug safety for most segments of the population, pregnant women constitute one special group that is “orphaned” with respect to this issue. The lack of adequate pregnancy safety information for the vast majority of medications, combined with a need to make appropriate treatment decisions and to communicate risk information to a potentially vulnerable population, are some of the most challenging and critical women's health issues. Clinical Pharmacology & Therapeutics (2008) 83 , 181–183; doi: 10.1038/sj.clpt.6100448